Patent · US Active

CDK inhibitors

US9957276B2 · kind B2 · utility

7Cited by
13References
57Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2016
Grant dateMay 1, 2018
Priority date—
Expiry dateNov 10, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.